Small Activating RNAs: Towards the Development of New Therapeutic Agents and Clinical Treatments

• Main Authors: Hossein Ghanbarian, Shahin Aghamiri, Mohamad Eftekhary, Nicole Wagner, Kay-Dietrich Wagner
• Format: Article
• Language: English
• Published: MDPI AG 2021-03-01
• Series: Cells
• Subjects: small interfering RNAs (siRNAs); microRNAs (miRNAs); small activating RNAs (saRNA); molecular mechanism; neuronal development; cardiac development
• Online Access: https://www.mdpi.com/2073-4409/10/3/591

Small double-strand RNA (dsRNA) molecules can activate endogenous genes via an RNA-based promoter targeting mechanism. RNA activation (RNAa) is an evolutionarily conserved mechanism present in diverse eukaryotic organisms ranging from nematodes to humans. Small activating RNAs (saRNAs) involved in RNAa have been successfully used to activate gene expression in cultured cells, and thereby this emergent technique might allow us to develop various biotechnological applications, without the need to synthesize hazardous construct systems harboring exogenous DNA sequences. Accordingly, this thematic issue aims to provide insights into how RNAa cellular machinery can be harnessed to activate gene expression leading to a more effective clinical treatment of various diseases.